T2 BIOSYSTEMS INC
(89853L104)
ファンドの報告 T2 BIOSYSTEMS INC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Senvest Management LLC | 886,478 | $1,489k | Jun 30, 2019 | Aug 13, 2019 | |
| Point72 Asset Management LP | 600,000 | $1,008k | Jun 30, 2019 | Aug 14, 2019 | |
| Gagnon Securities LLC | 149,065 | $250k | Jun 30, 2019 | Aug 12, 2019 | |
| Merriman Wealth Management LLC | 12,100 | $204k | Jun 30, 2019 | Jul 31, 2019 | |
| Wiley Bros-Aintree Capital LLC | 25,000 | $42k | Jun 30, 2019 | Jul 10, 2019 | |
| Gabelli Funds LLC | 13,000 | $22k | Jun 30, 2019 | Aug 2, 2019 | |
| First Manhattan Co | 450 | $0k | Jun 30, 2019 | Aug 16, 2019 |